Examples of using Multi-centre in English and their translations into Norwegian
{-}
-
Colloquial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
The safety and efficacy of Eylea were assessed in a randomised, multi-centre, double-masked, active- controlled study in patients with macular oedema secondary to BRVO(VIBRANT) which included Hemi-Retinal Vein Occlusion.
Phase 3, multi-centre, open and randomized study to compare the safety
The efficacy of the medicinal product was evaluated in a multi-centre, case-series, non-controlled,
A multi-centre, phase II,
Two randomised, double-blind, multi-centre, placebo-controlled studies have been conducted in 32(study AC-052-351)
placebo-controlled, multi-centre studies of clinically stable patients with CF who had the G551D mutation in the CFTR gene on at least 1 allele and had FEV1≥40% predicted.
In a multi-centre(US, Canada), parallel-group, double-blind, placebo-controlled study,
Two randomised, double-blind, multi-centre, placebo-controlled studies have been conducted in 122(study AC-052-401[RAPIDS-1])
To conduct a single-arm open-label, multi-centre efficacy and safety study of.
Two randomized, double-blind, multi-centre, placebo-controlled trials were conducted to demonstrate efficacy.
double-blind, multi-centre trial in patients with functional carcinoid tumours, Afinitor plus depot octreotide was compared to placebo
A pivotal phase 3, multi-centre, international, randomized,
The efficacy of metaphylactic use of Zuprevo was demonstrated in a placebo controlled multi-centre field study, when outbreak of clinical disease was confirmed i.e.
AC-052-355 was a multi-centre, randomised, double- blind,
Two randomised, double-blind, multi-centre, placebo controlled, Phase 3 pivotal studies were conducted ARIES-1 and 2.
The efficacy of Fortacin was demonstrated in two multi-centre, multinational, randomised,
The once daily regimen of abacavir is supported by a 48 weeks multi-centre, double-blind, controlled study(CNA30021)
ezetimibe therapy was assessed in a multi-centre, randomised, double-blind,
The efficacy and safety of degarelix was evaluated in an open-label, multi-centre, randomised, active comparator controlled, parallel-group study.
Three multi-centre, open-labelled, non-controlled trials have been conducted to evaluate the safety